Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each individual tumour comprises multiple sub-populations of genetically-distinct cells that may respond differently to targeted therapies and may contribute to disappointing clinical trial results. Image-localized biopsy techniques allow multiple biopsies to be taken during surgery and provide information that identifies regions where particular sub-populations occur within an individual GBM, thus providing insight into their regional genetic variability. These sub-populations may also interact with one another in some way; it is important to ascertain the nature of these interactions, as they may have implications for responses to targeted therapies...
Despite a low overall mutational burden, paediatric high-grade gliomas (pHGG) display high intra-tum...
AbstractMATERIALS AND METHODS: We examined pretreatment magnetic resonance imaging (MRI) examination...
The Cancer Genome Atlas Network recently catalogued recurrent genomic abnormalities in glioblastoma ...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumour with 5-year survival rates...
The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in glioblastoma m...
Glioblastoma multiforme (GBM) is the most aggressive and malignant among brain tumors. In addition ...
SummaryThe Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in gliobla...
Background. Glioblastoma (GBM) exhibits profound intratumoral genetic heterogeneity. Each tumor comp...
Glioblastoma (GBM) is known to be a heterogeneous disease; however, the genetic composition of the c...
Mathematical oncology provides unique and invaluable insights into tumour growth on both the microsc...
Background Glioblastoma is the most common and aggressive adult brain malignancy against which conve...
Background Glioblastoma is the most common and aggressive adult brain malignancy against which conve...
Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis an...
Despite a low overall mutational burden, paediatric high-grade gliomas (pHGG) display high intra-tum...
AbstractMATERIALS AND METHODS: We examined pretreatment magnetic resonance imaging (MRI) examination...
The Cancer Genome Atlas Network recently catalogued recurrent genomic abnormalities in glioblastoma ...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumour with 5-year survival rates...
The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in glioblastoma m...
Glioblastoma multiforme (GBM) is the most aggressive and malignant among brain tumors. In addition ...
SummaryThe Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in gliobla...
Background. Glioblastoma (GBM) exhibits profound intratumoral genetic heterogeneity. Each tumor comp...
Glioblastoma (GBM) is known to be a heterogeneous disease; however, the genetic composition of the c...
Mathematical oncology provides unique and invaluable insights into tumour growth on both the microsc...
Background Glioblastoma is the most common and aggressive adult brain malignancy against which conve...
Background Glioblastoma is the most common and aggressive adult brain malignancy against which conve...
Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis an...
Despite a low overall mutational burden, paediatric high-grade gliomas (pHGG) display high intra-tum...
AbstractMATERIALS AND METHODS: We examined pretreatment magnetic resonance imaging (MRI) examination...
The Cancer Genome Atlas Network recently catalogued recurrent genomic abnormalities in glioblastoma ...